Clinical TrialsSearch results
Number of results: 494
Recruiting
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Breast Cancer
- Inoguchi Akihiro
- 2023-01-22
Recruiting
- A study of dostarlimab in combination with carboplatin-paclitaxel in Japanese participants with primary advanced or recurrent endometrial cancer
- Endometrial Cancer
- Ishibashi Hideyasu
- 2024-03-28
Completed
- A study of DoTiNurad aiming to treat hyperuricemia with CKD
- Patients with hyperuricemia whose renal function is in the GFR range of G1 to G4
- Wada Jun
- 2022-02-22
Other
- A Study of JNJ-64407564 in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Fujikawa Ei
- 2021-04-01
Other
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (iinnovate-1)
- Multiple Myeloma
- Asato Takayuki
- 2022-12-26
Recruiting
- A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
- Locally Advanced, Unresectable, or Metastatic Non -Small Cell Lung Cancer
- Tsumura Akari
- 2021-09-28
Other
- A study of Teclistamab in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Hematologic Malignancies
- Nishikawa Kazuko
- 2021-01-29
Completed
- A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
- Takayasu Arteritis
- Nishikawa Kazuko
- 2021-05-28
Recruiting
- A Study of Zipalertinib and Chemotherapy Compared With Chemotherapy Alone in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion
- Locally advanced or metastatic nonsquamous NSCLC harboring EGFR exon 20 insertion mutations
- Dempke Wolfram
- 2023-09-12
Recruiting
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation
- Advanced/metastatic NSCLC with Exon 20 insertions and Uncommon/Single or Compound EGFR Mutations
- Dempke Wolfram
- 2023-09-12